Antares Pharma, Inc.

CIK 1016169 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Antares Pharma, Inc..

Recent SEC filings

FiledFormAccession number
Feb 10, 2023SC 13G/A0001172661-23-000627
Jun 3, 202215-12B0001193125-22-166727
May 31, 2022EFFECT9999999995-22-001650
May 31, 2022EFFECT9999999995-22-001625
May 31, 2022EFFECT9999999995-22-001632
May 31, 2022EFFECT9999999995-22-001627
May 31, 2022EFFECT9999999995-22-001628
May 31, 2022EFFECT9999999995-22-001651
May 31, 2022EFFECT9999999995-22-001626
May 31, 2022EFFECT9999999995-22-001629
May 31, 2022EFFECT9999999995-22-001631
May 31, 2022EFFECT9999999995-22-001652
May 31, 2022EFFECT9999999995-22-001624
May 26, 202240000899243-22-019782
May 26, 202240000899243-22-019789
May 26, 202240000899243-22-019784
May 26, 202240000899243-22-019793
May 26, 202240000899243-22-019794
May 26, 202240000899243-22-019780
May 26, 202240000899243-22-019786
May 26, 202240000899243-22-019783
May 26, 202240000899243-22-019792
May 26, 202240000899243-22-019796
May 26, 202240000899243-22-019797
May 24, 2022S-8 POS0001193125-22-158585